OBSERVATION OF ULINASTATIN COMBINED WITH SOMATOSTATIN IN TREATMENT OF SEVERE ACUTE PANCREATITIS
Piao Xi-x
Abstract
Piao Xi-x
Abstract
[Objective]To discuss the ulinastatin combined with somatostatin in treatment of severe acute pancreatitis.[Methods]62 patients diagnosed with severe acute pancreatitis were randomly divided into control group and treatment group,two groups were treated with conventional therapy,including fasting,gastrointestinal decompression,anti-inflammatory,inhibit pancreatic secretion symptomatic and supportive treatment.Treatment group based on the above was given ulinastatin,somatostatin,while somatostatin was used alone in the control group.14d was a course of treatment.Then compared the efficacy and clinical remission in the two groups.[Results]The extinction time of abdominal pain,the recovery time of urine amylase,the average hospitalization time in the treatment group were significantly shorter than in the control group(P﹤0.01).The total effective rate was statistically different(χ2 = 8.375,P﹤0.01).[Conclusion]Ulinastatin combined with somatostatin in treatment of severe acute pancreatitis has significant clinical effect,which can improve clinical symptoms and signs,it should be popularized and applied in clinic.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Objective]To discuss the ulinastatin combined with somatostatin in treatment of severe acute pancreatitis.[Methods]62 patients diagnosed with severe acute pancreatitis were randomly divided into control group and treatment group,two groups were treated with conventional therapy,including fasting,gastrointestinal decompression,anti-inflammatory,inhibit pancreatic secretion symptomatic and supportive treatment.Treatment group based on the above was given ulinastatin,somatostatin,while somatostatin was used alone in the control group.14d was a course of treatment.Then compared the efficacy and clinical remission in the two groups.[Results]The extinction time of abdominal pain,the recovery time of urine amylase,the average hospitalization time in the treatment group were significantly shorter than in the control group(P﹤0.01).The total effective rate was statistically different(χ2 = 8.375,P﹤0.01).[Conclusion]Ulinastatin combined with somatostatin in treatment of severe acute pancreatitis has significant clinical effect,which can improve clinical symptoms and signs,it should be popularized and applied in clinic.
Key concepts: Ulinastatin, Medicine, Somatostatin, Acute pancreatitis, Gastroenterology, Abdominal pain, Pancreatitis, Internal medicine